biology of incretins glp 1 and gip The incretin system: glucagon-like peptide-1 receptor agonists dipeptidyl peptidase-4 inhibitors in type 2 diabetes GIP and GLP‐1, the two
Description
Glucagon-Like Peptide-1 Receptor Agonists.[Updated 2023 Jan 13]

Pancreatic -cell mass is significantly reduced by more than 50% in patients with T2DM, with lesser reductions already occurring in the prediabetes state (124)
Compr Physiol 10: 577-595, 2020

the peak response was at 120 min

ongoing subscription disclosed at enrollment Pharmacy: State-licensed compounding (specific partner not publicly named)

Final Takeaway The new research gives patients a hopeful message
